X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (56285) 56285
Publication (2979) 2979
Newsletter (333) 333
Book Review (248) 248
Magazine Article (204) 204
Book / eBook (111) 111
Book Chapter (111) 111
Conference Proceeding (82) 82
Newspaper Article (65) 65
Dissertation (51) 51
Web Resource (22) 22
Data Set (8) 8
Reference (4) 4
Trade Publication Article (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52027) 52027
male (31292) 31292
female (27261) 27261
middle aged (26345) 26345
aged (22777) 22777
esophageal neoplasms - pathology (17518) 17518
index medicus (16624) 16624
adult (15030) 15030
esophageal neoplasms - surgery (14523) 14523
esophageal cancer (13402) 13402
oncology (11728) 11728
cancer (11541) 11541
surgery (10659) 10659
prognosis (7435) 7435
gastroenterology & hepatology (7189) 7189
aged, 80 and over (7002) 7002
carcinoma, squamous cell - pathology (6623) 6623
esophageal neoplasms - mortality (6111) 6111
esophageal neoplasms - therapy (5588) 5588
neoplasm staging (5488) 5488
treatment outcome (5458) 5458
retrospective studies (5452) 5452
carcinoma (5395) 5395
esophageal neoplasms - diagnosis (5316) 5316
esophageal neoplasms - genetics (5258) 5258
adenocarcinoma (5239) 5239
esophagus (5008) 5008
risk factors (4901) 4901
esophageal neoplasms - drug therapy (4673) 4673
adenocarcinoma - pathology (4619) 4619
esophageal neoplasms (4491) 4491
esophagectomy (4243) 4243
carcinoma, squamous cell - surgery (4152) 4152
esophageal neoplasms - metabolism (4100) 4100
follow-up studies (3817) 3817
squamous-cell carcinoma (3817) 3817
esophageal neoplasms - radiotherapy (3804) 3804
squamous cell carcinoma (3770) 3770
chemotherapy (3723) 3723
survival rate (3546) 3546
esophageal neoplasms - epidemiology (3410) 3410
esophageal squamous cell carcinoma (3359) 3359
esophageal neoplasms - diagnostic imaging (3326) 3326
esophageal neoplasms - complications (3317) 3317
animals (3310) 3310
lymphatic metastasis (3296) 3296
combined modality therapy (3255) 3255
care and treatment (3236) 3236
research (3116) 3116
adenocarcinoma - surgery (3112) 3112
immunohistochemistry (3092) 3092
analysis (3079) 3079
tumors (2994) 2994
esophagoscopy (2967) 2967
esophageal neoplasms - etiology (2929) 2929
survival (2923) 2923
carcinoma, squamous cell - genetics (2901) 2901
expression (2831) 2831
medicine & public health (2820) 2820
carcinoma, squamous cell - mortality (2724) 2724
esophagus - pathology (2686) 2686
metastasis (2669) 2669
radiotherapy (2668) 2668
esophagectomy - methods (2578) 2578
cell line, tumor (2576) 2576
antineoplastic combined chemotherapy protocols - therapeutic use (2537) 2537
health aspects (2532) 2532
time factors (2429) 2429
stomach neoplasms - pathology (2407) 2407
stomach neoplasms - surgery (2357) 2357
survival analysis (2347) 2347
carcinoma, squamous cell - metabolism (2344) 2344
prospective studies (2335) 2335
barrett esophagus - pathology (2329) 2329
diagnosis (2301) 2301
risk (2210) 2210
endoscopy (2112) 2112
carcinoma, squamous cell - therapy (2104) 2104
chemoradiotherapy (2085) 2085
mortality (2071) 2071
biopsy (1968) 1968
abridged index medicus (1967) 1967
case-control studies (1932) 1932
pathology (1909) 1909
esophagus - surgery (1903) 1903
tomography, x-ray computed (1902) 1902
therapy (1894) 1894
radiography (1876) 1876
gene expression regulation, neoplastic (1863) 1863
carcinoma, squamous cell - drug therapy (1860) 1860
incidence (1813) 1813
palliative care (1764) 1764
neoplasm invasiveness (1745) 1745
diagnosis, differential (1740) 1740
neoplasms (1731) 1731
apoptosis (1682) 1682
barretts-esophagus (1682) 1682
radiology, nuclear medicine & medical imaging (1676) 1676
adenocarcinoma - mortality (1644) 1644
cisplatin - administration & dosage (1547) 1547
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (71) 71
Online Resources - Online (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Credit Valley Hospital - Stacks (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
OISE - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (45761) 45761
Japanese (2734) 2734
German (1970) 1970
Chinese (1711) 1711
French (1707) 1707
Russian (1546) 1546
Spanish (329) 329
Italian (294) 294
Polish (208) 208
Portuguese (167) 167
Korean (132) 132
Hungarian (117) 117
Czech (108) 108
Danish (63) 63
Dutch (59) 59
Croatian (38) 38
Romanian (32) 32
Swedish (30) 30
Norwegian (24) 24
Hebrew (21) 21
Slovak (20) 20
Bulgarian (19) 19
Serbian (19) 19
Finnish (15) 15
Ukrainian (13) 13
Lithuanian (7) 7
Turkish (6) 6
Afrikaans (5) 5
Greek (3) 3
Icelandic (2) 2
Persian (2) 2
Arabic (1) 1
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
2005, Medical clinics of North America, ISBN 1416027238, Volume 89, no. 2., xiv p., p. [219]-418
Book
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2010, Volume 102, Issue 1, pp. 220 - 226
BACKGROUND: Radiotherapy for breast cancer reduces disease recurrence and breast cancer mortality. However, it has also been associated with increased second... 
Risk | Breast cancer | Radiotherapy | Second primary neoplasms | Radiation | MORTALITY | QUALITY | LUNG-CARCINOMA | breast cancer | second primary neoplasms | RADIATION-THERAPY | WOMEN | IRRADIATION | CONTRALATERAL BREAST | ONCOLOGY | radiation | INCREASED RISK | radiotherapy | EXPOSURES | risk | SURVIVORS | Esophageal Neoplasms - etiology | Breast Neoplasms - surgery | United States - epidemiology | Soft Tissue Neoplasms - etiology | Follow-Up Studies | Humans | Middle Aged | Breast Neoplasms - etiology | Mastectomy - methods | National Cancer Institute (U.S.) | Bone Neoplasms - epidemiology | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Esophageal Neoplasms - epidemiology | Lung Neoplasms - etiology | Registries - statistics & numerical data | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Mastectomy - statistics & numerical data | Soft Tissue Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Pleural Neoplasms - epidemiology | Survivors | Combined Modality Therapy | Radiotherapy - statistics & numerical data | Breast Neoplasms - drug therapy | Bone Neoplasms - etiology | Pleural Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Breast Neoplasms - radiotherapy | Lung Neoplasms - epidemiology | Aged | Neoplasms, Radiation-Induced - epidemiology | Epidemiology
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 2010, Volume 172, Issue 1, pp. 21 - 35
Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the correlates of vitamin D status will help guide... 
Body mass index | Exercise | Diet | Vitamin D | Cohort studies | Dietary supplements | Ethnic groups | Seasons | Endometrial Neoplasms - ethnology | Stomach Neoplasms - ethnology | United States - epidemiology | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Prospective Studies | Vitamin D Deficiency - complications | Humans | Esophageal Neoplasms - ethnology | Esophageal Neoplasms - prevention & control | Male | Neoplasms - prevention & control | Kidney Neoplasms - prevention & control | Case-Control Studies | Endometrial Neoplasms - prevention & control | Esophageal Neoplasms - epidemiology | Ovarian Neoplasms - ethnology | Neoplasms - ethnology | Lymphoma, Non-Hodgkin - prevention & control | Lymphoma, Non-Hodgkin - ethnology | Adult | Female | Stomach Neoplasms - epidemiology | Pancreatic Neoplasms - prevention & control | Kidney Neoplasms - ethnology | Ovarian Neoplasms - prevention & control | Risk Factors | Logistic Models | China - epidemiology | Endometrial Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - epidemiology | Ovarian Neoplasms - epidemiology | Vitamin D - blood | Vitamin D Deficiency - ethnology | Vitamin D Deficiency - prevention & control | Analysis of Variance | Vitamin D Deficiency - epidemiology | Stomach Neoplasms - prevention & control | Vitamin D - therapeutic use | Finland - epidemiology | Pancreatic Neoplasms - ethnology | Cohort Studies | Vitamin D deficiency | Complications and side effects | Calcifediol | Alfacalcidol | Seasonal variations (Diseases) | Research | Health aspects | Risk factors | seasons | Original Contributions | body mass index | vitamin D | ethnic groups | cohort studies | dietary supplements | exercise | diet
Journal Article
Radiology, ISSN 0033-8419, 05/2004, Volume 231, Issue 2, pp. 305 - 332
Positron emission tomography (PET) provides metabolic information that has been documented to be useful in patient care. The properties of positron decay... 
Lymphoma, PET | Melanoma | Gastrointestinal tract, PET | Breast neoplasms, PET | Review | Lung neoplasms, PET | Head and neck neoplasms, PET | CUTANEOUS MALIGNANT-MELANOMA | SENTINEL NODE BIOPSY | breast neoplasms, PET | OCCULT PRIMARY TUMORS | METASTATIC COLORECTAL-CARCINOMA | F-18 FLUORODEOXYGLUCOSE PET | melanoma | WHOLE-BODY PET | NERVOUS-SYSTEM LESIONS | CELL LUNG-CANCER | lung neoplasms, PET | POSITRON-EMISSION-TOMOGRAPHY | review | lymphoma, PET | NON-HODGKINS-LYMPHOMA | gastrointestinal tract, PET | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | head and neck neoplasms, PET | Melanoma - diagnostic imaging | Prognosis | Lymphoma - diagnostic imaging | Humans | Thyroid Neoplasms - diagnostic imaging | Lung Neoplasms - pathology | Esophageal Neoplasms - pathology | Neoplasms - therapy | Lymphoma - pathology | Breast Neoplasms - diagnostic imaging | Physical Phenomena | Carcinoma, Non-Small-Cell Lung - pathology | Head and Neck Neoplasms - diagnostic imaging | Colorectal Neoplasms - diagnostic imaging | Melanoma - pathology | Neoplasms - diagnostic imaging | Physics | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Lung Neoplasms - diagnostic imaging | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Tomography, Emission-Computed | Colorectal Neoplasms - pathology | Neoplasm Staging | Neoplasms - pathology | Esophageal Neoplasms - diagnostic imaging
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1833-3516, 04/2018, Volume 2018, Issue 4, pp. 116 - 117
Background Cancer is a common disease and radiotherapy is one well-established treatment for some solid tumours. Hyperbaric oxygenation therapy (HBOT) may... 
Medicine | Evidence | Reprinted from | Abstract | Cancer | CLINICAL-TRIAL | Radiation Tolerance | Humans | Male | Combined Modality Therapy [methods] | NECK-CANCER | RANDOMIZED TRIAL | Bronchial Neoplasms [mortality; radiotherapy] | UTERINE CERVIX | MEDICINE, GENERAL & INTERNAL | Time Factors | Uterine Cervical Neoplasms [mortality; radiotherapy] | Hyperbaric Oxygenation [adverse effects; methods] | Female | Esophageal Neoplasms [mortality; radiotherapy] | Head and Neck Neoplasms [mortality; radiotherapy] | RESEARCH-COUNCIL TRIAL | THERAPY ONCOLOGY GROUP | Randomized Controlled Trials as Topic | Rectal Neoplasms [mortality; radiotherapy] | RADIATION-THERAPY | Neoplasm Recurrence, Local [epidemiology] | INTERIM-REPORT | FINAL REPORT | Urinary Bladder Neoplasms [mortality; radiotherapy] | CARCINOMA | Neoplasms [mortality; radiotherapy] | Urinary Bladder Neoplasms - mortality | Bronchial Neoplasms - mortality | Uterine Cervical Neoplasms - radiotherapy | Neoplasms - mortality | Esophageal Neoplasms - radiotherapy | Hyperbaric Oxygenation - adverse effects | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Head and Neck Neoplasms - radiotherapy | Bronchial Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Hyperbaric Oxygenation - methods | Esophageal Neoplasms - mortality | Neoplasms - radiotherapy | Combined Modality Therapy - methods | Neoplasm Recurrence, Local - epidemiology | Head and Neck Neoplasms - mortality | Uterine Cervical Neoplasms - mortality | Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2018, Volume 118, Issue 3, pp. 428 - 434
Background: Periodontal pathogens have been linked to oral and gastrointestinal (orodigestive) carcinogenesis. However, the exact mechanisms remain unknown.... 
chymotrypsin-like proteinase | Treponema denticola | periodontopathogen | COLLAGENASE-2 MMP-8 | PORPHYROMONAS-GINGIVALIS | PANCREATIC-CANCER | TISSUE INHIBITORS | PERIODONTAL-DISEASE | METALLOPROTEINASES | ONCOLOGY | gastrointestinal cancer | ALPHA-1-ANTITRYPSIN | EXPRESSION | oral cancer | HUMAN NEUTROPHIL | PROGRESSION | Digestive System Neoplasms - metabolism | Pancreatic Neoplasms - chemistry | Adenocarcinoma - pathology | Pancreatic Neoplasms - metabolism | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Treponema denticola - enzymology | Mouth Neoplasms - metabolism | Stomach Neoplasms - pathology | Tonsillar Neoplasms - chemistry | Complement C1q - metabolism | Colonic Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Esophageal Neoplasms - pathology | Tonsillar Neoplasms - metabolism | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Head and Neck Neoplasms - chemistry | Matrix Metalloproteinase 9 - metabolism | Adenocarcinoma - metabolism | Matrix Metalloproteinase 8 - metabolism | Esophageal Neoplasms - metabolism | Digestive System Neoplasms - pathology | Colonic Neoplasms - chemistry | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Tonsillar Neoplasms - pathology | Pancreatic Neoplasms - pathology | Carcinoma, Squamous Cell - chemistry | Mouth Neoplasms - chemistry | Head and Neck Neoplasms - pathology | Cell Transformation, Neoplastic - immunology | Digestive System Neoplasms - chemistry | alpha 1-Antichymotrypsin - metabolism | Colonic Neoplasms - pathology | Chymases - analysis | Mouth Neoplasms - pathology | Immunohistochemistry | Proteinase | Virulence | Tissue inhibitor of metalloproteinase 2 | Tissues | Tissue inhibitor of metalloproteinase 1 | Carcinogenesis | Proteins | Carcinogens | Pancreatic carcinoma | Bacteria | Colon | Pancreas | Gastric cancer | Squamous cell carcinoma | Tonsil | Immunomodulation | Teeth | Proteinase inhibitors | Esophagus | Complement component C1q | Chymotrypsin | Periodontitis | Neutrophil collagenase | Tumors | Molecular Diagnostics
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 03/2015, Volume 65, Issue 2, pp. 87 - 108
Journal Article